Cold agglutinin disease (CAD) is marked by the destruction of red blood cells, cells essential to transporting oxygen to tissues. Their loss can lead to symptoms that include joint pain, fatigue, and cardiac issues. Your doctor may recommend a blood transfusion to help ease these symptoms. Here are answers to some frequently…
FAQs
Cold agglutinin disease (CAD) is a rare disorder in which the immune system produces autoantibodies that attack the body’s own red blood cells when exposed to cold temperatures. Plasmapheresis can provide temporary relief of symptoms by removing autoantibodies from the blood. Here Following are a few frequently asked questions…
A leading treatment for cold agglutinin disease (CAD) is rituximab. Following  are answers to some questions you might have before you decide to start treatment. How does rituximab work? CAD is caused by immune cells in the body called B-cells producing antibodies that bind to red…
A diagnosis of cold agglutinin disease (CAD) can be challenging for patients and their families. As a rare disease, it can be difficult to find information about CAD or its treatments. To help, below are answers to some frequently asked questions about CAD. What is CAD? CAD is a…
Recent Posts
- Genetic variations in underlying lymphoma influence AIHA types
- Lessons from ‘Winnie-the-Pooh’ help me navigate life with CAD
- Cost-effective rituximab-based treatment keeps CAD at bay for years
- This year, ongoing CAD symptoms dampened my holiday cheer
- Immunochemotherapy can help control CAD but it carries safety risks
- Oral therapy iptacopan eases anemia in CAD patients: Small trial
- When living with CAD, even a short trip can be a nightmare
- Real-world study confirms long-term safety of Enjaymo for CAD
- After months of fatigue, feeling better is what I want for Christmas
- Man’s case shows bacterial lung infection can ‘provoke’ clots, CAD